SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, attributed to stronger demand for Amtagvi and Proleukin, is driving the discussion, with traders viewing it as evidence of improving commercial momentum. The reaction is broadly bullish, while short-squeeze and takeover talk remains speculative and many are watching for upcoming lung-cancer data.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles change-of-control severance policy has fueled buyout speculation, though traders disagree on whether it hints at a potential deal or is routine governance, and the policy itself does not confirm an acquisition. The discussion also reflects frustration over limited updates on BlueBird satellite shipments and launch timing.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals prolonged slide and upcoming Q3 report have traders focused on whether elevated fuel costs tied to Middle East tensions will pressure guidance and earnings. Bulls call the stock oversold and point to strong demand, while bears warn that sustained high oil prices and uncertain outlook could extend the decline.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFA changes allowing VantageScore alongside FICO in Fannie Mae and Freddie Mac mortgage pricing have raised concerns that competition could erode FICOs longstanding mortgage-scoring advantage and pricing power. Traders debate whether the selloff reflects a lasting threat to revenue and the companys valuation or an overreaction given FICOs broader business and continued strength.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is drawing attention after four-year AMT-130 Huntingtons disease data showed less slowing on the cUHDRS measure than at three years, with the result no longer statistically significant, prompting a sharp selloff. Traders debate whether the longer-term results weaken the FDA case or whether the BLA, based on the stronger three-year data, and significant TFC results still support approval.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic equity investment and clinical collaboration around ivonescimab drove a sharp move in SMMT, with traders viewing the deal as added funding and validation for Summits cancer drug program. The community debated whether the investment signals confidence ahead of the FDA decision, while others cautioned that it is not a buyout and does not determine the regulatory outcome.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop next-generation 10 kV silicon-carbide devices has driven attention, with traders treating it as technology and domestic-manufacturing validation and speculating about short-covering. Others caution that it is a prototype program with undisclosed financial terms, so the near-term revenue impact is unclear and the initial rally could fade.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists new ITC complaint alleges that Microns HBM products infringe its patents and seeks import-exclusion and cease-and-desist orders against Micron and downstream customers Nvidia, Broadcom, and Google. Many traders view the filing as added leverage for a potential Micron licensing deal, while others caution that settlement timing and outcome are uncertain and point to disappointing share-price action.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCN is drawing attention after a sharp rebound, with traders calling a technical breakout and speculating about Robinhood-related exposure and Zebecs payroll and card adoption as possible tailwinds. Those catalysts are not uniformly seen as confirmed or price-moving, and skeptics point to repeated reversals and the need for stronger evidence of real usage and token demand.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

UECs fiscal 2026 results and operating update are driving discussion, with traders highlighting higher production, Burke Hollows contribution, and a debt-free balance sheet with substantial liquidity. Reactions are broadly encouraged by the execution and domestic uranium-growth story, though some remain cautious about ongoing losses and the stocks weak price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BCRX look at the $CRNX buyout after the close, the premium is insane.  You can see a nice prem on $BCRX $18-$25  
Lets see if Betaville rumors add up

ktrader1991

Money Mane

Anthony

Rick Glowaki

Jake

Stash_Cash

Rick P

Smnorgy Roni

Larry

angeloc441

Carl Burt

Jeffrey S Fore

Gud2trad3

Ron Jansen

Kranti

StockTwits Web

Biocryst Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc

 buyout after the close, the premium is insane.  You can see a nice prem on 

 $18-$25  
Lets see if Betaville rumors add up

@Buysidetrader69 

Crinetics revenue was $7.7 million for the year ended December 31, 2025

StockTwits for iOS

 

Crinetics revenue was $7.7 million for the year ended December 31, 2025

gdesivir

@Buysidetrader69  98.43% that&#39;s encouraging.

Ismael

@Buysidetrader69  Also in the 5 days before the buy out it was up 14.52%. In the month before the buy out it was up 27.67%

  Also in the 5 days before the buy out it was up 14.52%. In the month before the buy out it was up 27.67%

@Buysidetrader69  The 12 billion they have in cash helped, but their revenues of 18 million did not, so the buy out is based on future sales projections.

  The 12 billion they have in cash helped, but their revenues of 18 million did not, so the buy out is based on future sales projections.